Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
复制标题
DOI:
10.1016/j.virol.2013.10.035
复制
发表时间:
2014-01-20
期刊:
影响因子:
3.7
通讯作者:
Steinmetz NF
中科院分区:
文献类型:
--
作者:
Bruckman MA;Randolph LN;VanMeter A;Hern S;Shoffstall AJ;Taurog RE;Steinmetz NF
Understanding the pharmacokinetics, blood compatibility, biodistribution and clearance properties of nanoparticles is of great importance to their translation to clinical application. In this paper we report the biodistribution and pharmacokinetic properties of tobacco mosaic virus (TMV) in the forms of 300×18 nm rods and 54 nm-sized spheres. The availability of rods and spheres made of the same protein provides a unique scaffold to study the effect of nanoparticle shape on in vivo fate. For enhanced biocompatibility, we also considered a PEGylated formulation. Overall, the versions of nanoparticles exhibited comparable in vivo profiles; a few differences were noted: data indicate that rods circulate longer than spheres, illustrating the effect that shape plays on circulation. Also, PEGylation increased circulation times. We found that macrophages in the liver and spleen cleared the TMV rods and spheres from circulation. In the spleen, the viral nanoparticles trafficked through the marginal zone before eventually co-localizing in B-cell follicles. TMV rods and spheres were cleared from the liver and spleen within days with no apparent changes in histology, it was noted that spheres are more rapidly cleared from tissues compared to rods. Further, blood biocompatibility was supported, as none of the formulations induced clotting or hemolysis. This work lays the foundation for further application and tailoring of TMV for biomedical applications.
登录
查看更多内容
影响因子:
5.5
作者:
FITCHEN, J;BEACHY, RN;HEIN, MB
通讯作者:
HEIN, MB
影响因子:
3.2
作者:
Bruckman, Michael A.;Kaur, Gagandeep;Wang, Qian
通讯作者:
Wang, Qian
DOI:
10.1016/j.ejpb.2010.11.010
发表时间:
2011-04
期刊:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
影响因子:
--
作者:
Arnida;Janát-Amsbury MM;Ray A;Peterson CM;Ghandehari H
通讯作者:
Ghandehari H
影响因子:
3.8
作者:
Atabekov, Joseph;Nikitin, Nikolai;Karpova, Olga
通讯作者:
Karpova, Olga
影响因子:
2.2
作者:
Gad, Shayne C.;Sharp, Kelly L.;Goodrich, Glenn P.
通讯作者:
Goodrich, Glenn P.